QQ客服 官方微博 反馈留言

	Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma
	Zhao, Hai-Tao; Chen, Jing; Shi, Sheng-bin; Tian, Jing; Tao, Rong-Jie
刊名	MEDICAL ONCOLOGY
	2015
卷号	32期号:1页码:1-5
关键词	Primary central nervous system lymphoma Pemetrexed Rituximab Second-line treatment
DOI	10.1007/s12032-014-0351-7
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4775415
专题	山东大学
作者单位	1.Shan Dong Tumor Hosp, Dept Neurosurg, Jinan 250117, Shandong, Peoples R China. 2.Shandong Univ, Jinan Cen
推荐引用方式 GB/T 7714	Zhao, Hai-Tao,Chen, Jing,Shi, Sheng-bin,et al. Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma[J]. MEDICAL ONCOLOGY,2015,32(1):1-5.
APA	Zhao, Hai-Tao,Chen, Jing,Shi, Sheng-bin,Tian, Jing,&Tao, Rong-Jie.(2015).Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma.MEDICAL ONCOLOGY,32(1),1-5.
MLA	Zhao, Hai-Tao,et al."Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma".MEDICAL ONCOLOGY 32.1(2015):1-5.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。